Vaxart

VaxartVaxart
Vaxart

Vaxart

Vaxart is a clinical-stage biotechnology company developing oral vaccines for infectious diseases.

DR 511998Active108South San Francisco, United States
Rate

About

Vaxart is a biotechnology company focused on developing oral vaccines for a range of infectious diseases, including COVID-19, influenza, and norovirus. Their proprietary oral tablet vaccine platform aims to provide a more convenient and accessible alternative to traditional injectable vaccines.
Frequently asked

What does Vaxart do?

Vaxart is a biotechnology company focused on developing oral vaccines for a range of infectious diseases, including COVID-19, influenza, and norovirus. Their proprietary oral tablet vaccine platform aims to provide a more convenient and accessible alternative to traditional injectable vaccines.

What is Vaxart's revenue?

StartupHub estimates Vaxart's annual revenue at $15.8M (range $9.3M to $25.8M, 64% confidence), based on comparable companies in the sector.

Where is Vaxart headquartered?

Vaxart is headquartered in South San Francisco, United States.

When was Vaxart founded?

Vaxart was founded in 1998.

What industry does Vaxart operate in?

Vaxart operates in Biotech, MedTech, HealthTech, Vaccines, Drug Discovery, Clinical Trials.

How many employees does Vaxart have?

Vaxart has approximately 108 people on record.

HEADCOUNT
108
DOMAIN RATING
51
Comments

No comments yet. Be the first to share your take.